Intellia Therapeutics Inc.

NASDAQ: NTLA
$43.81
+$0.90 (+2.1%)
Closing price May 25, 2022

Tuesday's Top Analyst Upgrades and Downgrades: Apple, Continental Resources, Bilibili, Eaton, Hershey, Meta Platforms, Nio, NOV, PayPal, Southern Company and More
Tuesday's top analyst upgrades and downgrades included Apple, Continental Resources, Bilibili, Eaton, Hershey, Meta Platforms, Nio, NOV, PayPal and Southern Company.
Lee Jackson
3 months ago
Last Updated: 3 months ago

Friday Afternoon Analyst Upgrades and Downgrades: Barrick Gold, Newmont, Salesforce and More
Friday afternoon's analyst upgrades and downgrades included Barrick Gold, Canadian National Railway, Community Health Systems, Editas Medicine, Intellia Therapeutics, Newmont and Salesforce.com.
Chris Lange
8 months ago

Why Cramer Thinks Companies Should Not Aspire to Meme Stock Status
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Chris Lange
10 months ago

Friday's Top Analyst Upgrades and Downgrades: Biogen, CME, Dropbox, DocuSign, Nvidia, Tilray and More
Friday's top analyst upgrades and downgrades included Biogen, CME, Dropbox, DocuSign, Nvidia, Ping Identity, Signet Jewelers and Tilray.
Chris Lange
11 months ago
Last Updated: 11 months ago

Etsy, Monster Beverage, Nokia and More Friday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Etsy, Fate Therapeutics, Intellia, Ionis, Monster Beverage and more.
Chris Lange
1 year ago

Domino's, Editas, Roblox, Teva, US Steel and More Tuesday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Domino’s Pizza, Editas Medicine, Roblox, Teva Pharmaceutical Industries and U.S. Steel.
Chris Lange
1 year ago
Last Updated: 9 months ago